Patents Assigned to Medgenn (Hong Kong) Ltd
  • Methods of treating cancer using a modified endostatin protein
    Patent number: 7470667
    Abstract: The present invention provides methods of treating an angiogenesis-related disease of a subject using a therapeutically effective amount of a modified endostatin protein. In particular, the methods encompass treating an angiogenesis-related disease of a subject using a combination of the modified endostatin, and a known cancer therapy agent such as a chemotherapy agent, or a radiotherapy agent.
    Type: Grant
    Filed: April 29, 2005
    Date of Patent: December 30, 2008
    Assignee: Medgenn (Hong Kong) Ltd
    Inventors: Yongzhang Luo, Zhuobing Zhang, Qingxin Lei, Yan Sun, Jinwan Wang